AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness
  • 4 years ago
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness
AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.



Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Recommended